Filed with ASX · · 19 pages · English
The presentation outlines the company's U.S. commercial launch progress and partnerships, particularly with Philips, as well as financial metrics such as revenue growth and cash position. Imricor reported a notable increase in revenue compared to the previous year, alongside a decrease in net loss, indicating improved financial health. The document serves as a summary of the company's activities and financial results for the third quarter, aimed at informing investors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Q3 Result Webinar Presentation November 13, 2026 Imricor's vision is to bring iMR to every cardiac centre in the world IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) WWW.IMRICOR.COM 1 Disclaimer The material contained in this document is a presentation of general background information on assumptions which...
Imricor Medical Systems, Inc. on 6ix
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems